Photo of Dawn Nolt, M.D., M.P.H.

Dawn Nolt M.D., M.P.H.

    • Associate Professor of Pediatrics, Division of Infectious Diseases School of Medicine

Dr. Nolt's research focuses on the human immune response against Mycobacterium tuberculosis, to better understand the CD8 T cell response during this chronic infection. Using immune and biochemical techniques, Dr. Nolt is exploring how this pathogen is displayed to CD8 T lymphocytes (in the context of HLA-I) by human dendritic cells. Antigen-specific studies (processing, presentation/loading) and HLA-I trafficking within the dendritic cells are key areas of interest in Dr. Nolt's laboratory. Results of Dr. Nolt's research will advance the field of immunobiology of tuberculosis, and contribute to the development of an improved vaccine against this deadly disease.

  • Residency:

    • Pediatrics, Baylor Affiliated Hospitals Residency, 1999
  • Fellowship:

    • Pediatric infectious diseases, University of Pittsburgh, 2002
  • Certifications:

    • American Board of Pediatrics (AAP), 1999

Memberships and associations

  • American Academy of Pediatrics


  • "Hypohidrotic ectodermal dysplasia, osteopetrosis, lymphedema, and immunodeficiency in an infant with multiple opportunistic infections" Pediatric Dermatology November 1 2014
  • "Survival with hypopituitarism from congenital syphilis." Pediatrics April 2002
  • "The Mycobacterium tuberculosis Phagosome Is a HLA-I Processing Competent Organelle" PLoS Pathogens April 2009
  • "Lymphocutaneous Nocardia brasiliensis infection" Pediatric Infectious Disease Journal  2000
  • "Multicentric reticulohistiocytosis" Pediatric Dermatology May 1 2015
  • "Intrathoracic disease from nontuberculous mycobacteria in children" Pediatrics November 2003
  • "Interleukin-12 Therapy Reduces the Number of Immune Cells and Pathology in Lungs of Mice Infected with Mycobacterium tuberculosis" Infection and Immunity May 2004
  • "Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis" Journal of Experimental Medicine May 21 2001
  • "Recommendations for prevention and control of influenza in children, 2015-2016" Pediatrics October 1 2015
  • "Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses" Journal of Immunology July 15 2005
  • "Influenza immunization for all health care personnel" Pediatrics October 1 2015
  • "Spectrum of clinical manifestations of West Nile virus infection in children" Pediatrics December 2004
  • "Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)" Pediatric Blood and Cancer July 1 2015
  • "Surveillance stool cultures" Pediatric Transplantation March 2006
  • "Countering vaccine hesitancy" Pediatrics September 1 2016
  • "Parental presence during treatment of ebola or other highly consequential infection" Pediatrics September 1 2016
  • "Recommendations for serogroup B meningococcal vaccine for persons 10 years and older" Pediatrics September 1 2016
  • "Medical versus nonmedical immunization exemptions for child care and school attendance" Pediatrics September 1 2016
  • "The use of systemic and topical fluoroquinolones" Pediatrics November 1 2016
  • "Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States" Pediatrics February 1 2017
  • "Practical approaches to optimize adolescent immunization" Pediatrics March 1 2017
  • "Recommended childhood and adolescent immunization schedule-United States, 2017" Pediatrics March 1 2017
  • "The need to optimize adolescent immunization" Pediatrics March 1 2017
  • "Elimination of perinatal hepatitis B" Pediatrics September 1 2017
  • "Staphylococcus aureus" Pediatrics in Review June 1 2018
  • "Recommendations for prevention and control of influenza in children, 2018-2019" Pediatrics October 1 2018
  • "Recommended childhood and adolescent immunization schedules" Pediatrics March 1 2019
  • "Sharing antimicrobial reports for pediatric stewardship (SHARPS)" Journal of the Pediatric Infectious Diseases Society January 1 2018
  • "Perioperative neutropenia is not an independent risk factor for infectious complications of central venous line placement in children" Journal of Pediatric Surgery January 1 2019

Additional information

Edit profile